Equities Analysts Set Expectations for Albemarle Q2 Earnings

Key Points

• Albemarle's Earnings Forecasts: KeyCorp analysts have revised their Q2 2025 EPS estimate for Albemarle down to ($0.48) from ($0.35), signaling continued financial struggles.
• Recent Performance: In its last quarterly earnings, Albemarle reported $0.11 EPS, significantly exceeding the consensus estimate of ($0.83), despite a 7% year-over-year revenue decline to $1.33 billion.
• Dividend Announcement: The company declared a quarterly dividend of $0.405, payable on October 1st, representing an annualized yield of 2.4%.

Albemarle Corporation (NYSE:ALB - Free Report) - Equities researchers at KeyCorp reduced their Q2 2025 earnings per share estimates for Albemarle in a note issued to investors on Tuesday, July 29th. KeyCorp analyst A. Yefremov now anticipates that the specialty chemicals company will earn ($0.48) per share for the quarter, down from their previous forecast of ($0.35). KeyCorp currently has a "Sector Weight" rating on the stock. The consensus estimate for Albemarle's current full-year earnings is ($0.04) per share. KeyCorp also issued estimates for Albemarle's Q3 2025 earnings at ($0.69) EPS, Q4 2025 earnings at ($0.67) EPS, FY2025 earnings at ($2.01) EPS and FY2026 earnings at $1.59 EPS.

ALB has been the topic of several other reports. UBS Group increased their target price on Albemarle from $57.00 to $62.00 and gave the stock a "sell" rating in a research report on Thursday, July 31st. Wells Fargo & Company cut their price objective on Albemarle from $75.00 to $70.00 and set an "equal weight" rating on the stock in a report on Friday. Morgan Stanley cut their price objective on Albemarle from $68.00 to $58.00 and set an "underweight" rating on the stock in a report on Tuesday, May 6th. Wall Street Zen upgraded Albemarle to a "sell" rating in a report on Monday, May 5th. Finally, Baird R W downgraded Albemarle from a "hold" rating to a "strong sell" rating in a report on Tuesday, July 29th. Six analysts have rated the stock with a sell rating, nine have issued a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $89.78.

Albemarle Price Performance

Shares of NYSE:ALB traded down $0.77 on Friday, hitting $67.80. The company had a trading volume of 1,222,326 shares, compared to its average volume of 3,453,557. The business has a 50 day moving average of $66.23 and a 200 day moving average of $68.68. Albemarle has a 52-week low of $49.43 and a 52-week high of $113.91. The company has a market cap of $7.98 billion, a PE ratio of -7.28 and a beta of 1.63. The company has a current ratio of 2.31, a quick ratio of 1.47 and a debt-to-equity ratio of 0.38.

Albemarle (NYSE:ALB - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The specialty chemicals company reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.83) by $0.94. Albemarle had a negative return on equity of 1.87% and a negative net margin of 18.61%. The business had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.23 billion. During the same period in the prior year, the business earned $0.04 earnings per share. The business's revenue was down 7.0% on a year-over-year basis.

Institutional Trading of Albemarle

Several large investors have recently made changes to their positions in the stock. Hantz Financial Services Inc. raised its holdings in Albemarle by 10,050.0% in the 2nd quarter. Hantz Financial Services Inc. now owns 406 shares of the specialty chemicals company's stock valued at $25,000 after acquiring an additional 402 shares in the last quarter. SJS Investment Consulting Inc. acquired a new position in Albemarle in the 1st quarter valued at approximately $32,000. CVA Family Office LLC raised its holdings in Albemarle by 7,257.1% in the 2nd quarter. CVA Family Office LLC now owns 515 shares of the specialty chemicals company's stock valued at $32,000 after acquiring an additional 508 shares in the last quarter. National Pension Service raised its holdings in Albemarle by 74.5% in the 1st quarter. National Pension Service now owns 452 shares of the specialty chemicals company's stock valued at $33,000 after acquiring an additional 193 shares in the last quarter. Finally, Pilgrim Partners Asia Pte Ltd acquired a new position in Albemarle in the 4th quarter valued at approximately $34,000. Institutional investors own 92.87% of the company's stock.

Albemarle Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 1st. Stockholders of record on Friday, September 12th will be paid a dividend of $0.405 per share. This represents a $1.62 annualized dividend and a dividend yield of 2.4%. The ex-dividend date is Friday, September 12th. Albemarle's dividend payout ratio is -17.38%.

About Albemarle

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.